EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 12-Jul-2025 07:11 ET (12-Jul-2025 11:11 GMT/UTC)

14-May-2025

Interplay between key proteins could serve as a target for cancer treatment

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

In a study published in Nature, University of Michigan researchers have identified that the balance between two proteins—STAT3 and STAT5—is important for making tumors vulnerable to immune checkpoint therapy, and targeting STAT3 degradation is a potential novel cancer immunotherapy strategy.

Journal: Nature
Funder: NIH/National Cancer Institute, University of Michigan

14-May-2025

Study reveals surprising side effects of high-dose radiation therapy

University of Chicago Medical Center
Peer-Reviewed Publication

In a new study published in Nature, researchers at the University of Chicago Medicine Comprehensive Cancer Center explore a surprising phenomenon in which high doses of radiation cause growth in existing metastatic tumors that weren’t directly treated with radiation.

Journal: Nature

14-May-2025

Combining laboratory techniques yields wealth of information about deadly brain tumors

Johns Hopkins Medicine
Peer-Reviewed Publication

Clinicians from the Johns Hopkins Kimmel Cancer Center and four other institutions have demonstrated that doctors can gain a wealth of knowledge about a patient’s cancer by using multiple laboratory techniques to study tumor tissue taken from needle biopsies of glioblastoma, a highly aggressive form of brain cancer.

Journal: Nature Communications

14-May-2025

A downside of taurine: it drives leukemia growth

University of Rochester Medical Center
Peer-Reviewed Publication

A study in Nature shows that leukemia cells drink up taurine, which is produced in the body and also consumed through foods and in energy drinks, and use it as fuel for growth. This highlights a potential to block taurine uptake as a possible treatment.

Journal: Nature
Funder: NIH/National Institutes of Health

14-May-2025

NIH researchers discover a new tissue biomarker for aggressive breast cancer risk and poorer survival

NIH/Office of the Director
Peer-Reviewed Publication

Researchers at the National Institutes of Health (NIH) have identified a series of changes in the architecture and cell composition of connective tissues of the breast, known as stromal tissue, that is associated with an increased risk of developing aggressive breast cancer among women with benign breast disease, and poorer rates of survival among women with invasive breast cancer. This process, which they call stromal disruption, could potentially be used as a biomarker to identify women with benign breast disease who are at high risk of developing aggressive breast cancers, as well as those with breast cancer who may be at increased risk of recurrence or death.

Journal: JNCI Journal of the National Cancer Institute
Funder: NIH/National Institutes of Health

14-May-2025

Blood type a identified as potential breast cancer risk factor

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY - May 14, 2025 – A new review paper was published in Volume 16 of Oncotarget on May 9, 2025, titled “Relationship between ABO blood group antigens and Rh factor with breast cancer: A systematic review and meta-analysis."

Journal: Oncotarget

14-May-2025

NCCN joins global cancer organizations for first-ever international training/mentoring meeting on cancer control plans

National Comprehensive Cancer Network
Meeting Announcement

The United States-based National Comprehensive Cancer Network is among groups from up to 75 countries taking part in the Cancer Planners Forum in Geneva, Switzerland.

14-May-2025

Epigenetics predicts the aggressiveness of Burkitt Lymphoma, a common pediatric tumor in developing countries

Josep Carreras Leukaemia Research Institute
Peer-Reviewed Publication

Researchers of the Cancer Epigenetics group at the Josep Carreras Leukaemia Research Institute have discovered that patients with Burkitt lymphoma — a common paediatric tumour in equatorial African countries and Latin America — can be classified into two main groups based on their epigenetic signature. The study, a high-level international collaboration co-led by Dr Manel Esteller, has demonstrated that one group, HypoBL, has a milder course of the disease, whereas the other, HyperBL, is associated with early relapses and shorter survival.

Journal: Blood Cancer Discovery

14-May-2025

Got data? Breastfeeding device measures babies’ milk intake in real time

Northwestern University
Peer-Reviewed Publication

New device can give peace of mind and reduce anxiety for breastfeeding moms. It uses bioimpedance, which is currently used to measure body fat, and streams clinical-grade data to a smartphone or tablet in real time. Developed by physicians and engineers, device was tested by new moms. Technology could particularly benefit fragile babies in the NICU, who have precise nutritional needs.

Journal: Nature Biomedical Engineering
Funder: Defense Health Agency, National Research Foundation of Korea, Haythornthwaite Foundation

14-May-2025

Adult-onset type 1 diabetes increases risk of cardiovascular disease and death

Karolinska Institutet
Peer-Reviewed Publication

A new study in the European Heart Journal shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease and death, and that those diagnosed later in life do not have a better prognosis than those diagnosed earlier. The study, conducted by researchers at Karolinska Institutet in Sweden, points to smoking, poor glucose control and obesity as the main risk factors.

Journal: European Heart Journal